Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Chembl3977876
2. Schembl12657948
3. 16134b0yth
4. Bdbm250635
5. Pl8177
6. Pl-8177
7. Us9447148, 9.3
8. 1309111-58-7
9. L-tryptophanamide, N-acetyl-l-norleucyl-l-.alpha.-glutamyl-l-histidyl-d-phenylalanyl-l-arginyl-3-amino-l-alanyl-, (2->6)-lactam
| Molecular Weight | 996.1 g/mol |
|---|---|
| Molecular Formula | C48H65N15O9 |
| XLogP3 | -0.7 |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 19 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 385 |
| Heavy Atom Count | 72 |
| Formal Charge | 0 |
| Complexity | 1910 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
18
PharmaCompass offers a list of PL8177 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right PL8177 manufacturer or PL8177 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred PL8177 manufacturer or PL8177 supplier.
PharmaCompass also assists you with knowing the PL8177 API Price utilized in the formulation of products. PL8177 API Price is not always fixed or binding as the PL8177 Price is obtained through a variety of data sources. The PL8177 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PL8177 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PL8177, including repackagers and relabelers. The FDA regulates PL8177 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PL8177 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A PL8177 supplier is an individual or a company that provides PL8177 active pharmaceutical ingredient (API) or PL8177 finished formulations upon request. The PL8177 suppliers may include PL8177 API manufacturers, exporters, distributors and traders.
PL8177 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PL8177 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PL8177 GMP manufacturer or PL8177 GMP API supplier for your needs.
A PL8177 CoA (Certificate of Analysis) is a formal document that attests to PL8177's compliance with PL8177 specifications and serves as a tool for batch-level quality control.
PL8177 CoA mostly includes findings from lab analyses of a specific batch. For each PL8177 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PL8177 may be tested according to a variety of international standards, such as European Pharmacopoeia (PL8177 EP), PL8177 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PL8177 USP).
